Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Less CPAP time linked to exacerbation in COPD/OSA overlap syndrome

Key clinical point: Among patients with COPD and OSA, lung function and CPAP use are independent predictors of COPD exacerbations and all‐cause mortality.

Major finding: The average time of CPAP use was significantly higher in patients with no recorded exacerbation: 285.4 min/night vs. 238.2 min/night.

Study details: A retrospective cohort study that included 92 patients with overlap syndrome who had a COPD exacerbation and 92 patients with overlap who did not.

Disclosures: The authors had no conflicts of interest.


Jaoude P et al. Clin Respir J. 2019 Aug 22. doi: 10.1111/crj.13079.